ArticleThe journal of nutrition, health & aging2026
Vitamin D status and sarcopenia in older adults: population-based evidence for synergy with diabetes and experimental validation in an aged diabetic rat model.
Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitamin D deficiency is common in older adults and may contribute to sarcopenia, but whether diabetes modifies this association and the underlying mechanisms remain unclear.
methodsWe used a population-based and experimental validation framework. In epidemiological analyses, 7,520 older adults from two nationally representative cohorts were included (HRS wave 13, n = 3,246; ELSA wave 6, n = 4,274). Sarcopenia was defined according to EWGSOP2 criteria using low grip strength and low muscle mass estimated by a validated anthropometric equation standardized by BMI. Serum 25(OH)D was categorized as low (≤50 nmol/L) or higher (>50 nmol/L). Multivariable logistic regression with multiple imputation was used to assess overall and diabetes-stratified associations, as well as multiplicative and additive interactions. For experimental validation, an aged diabetic rat model with vitamin D deficiency was established, followed by vitamin D3 supplementation (2000 IU). Glycometabolic indices, muscle function and morphology, intramuscular lipid deposition, and senescence-related markers in gastrocnemius muscle were evaluated.
resultsLow 25(OH)D was associated with higher odds of sarcopenia overall. Among participants with diabetes, this association was stronger and reached statistical significance in ELSA (HRS: OR = 1.778, 95% CI 0.843-3.750; ELSA: OR = 2.242, 95% CI 1.055-4.764). In ELSA, the joint exposure to low 25(OH)D and diabetes was associated with increased sarcopenia odds (OR = 1.66, 95% CI 1.06-2.61), with evidence of additive interaction (RERI = 1.08, 95% CI 0.25-1.97). In aged diabetic rats, vitamin D deficiency aggravated hyperglycemia, insulin resistance, intramuscular lipid accumulation, and muscle senescence, whereas vitamin D3 supplementation improved muscle strength, myofiber cross-sectional area, and lipid infiltration.
conclusionsLow vitamin D status was associated with higher sarcopenia risk, particularly in diabetes. Experimental findings further support a protective role of vitamin D against diabetes-related muscle deterioration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.